Explaining the decrease in U.S. deaths from coronary disease, 1980-2000
Earl S Ford, Umed A Ajani, Janet B Croft, Julia A Critchley, Darwin R Labarthe, Thomas E Kottke, Wayne H Giles, Simon Capewell, Earl S Ford, Umed A Ajani, Janet B Croft, Julia A Critchley, Darwin R Labarthe, Thomas E Kottke, Wayne H Giles, Simon Capewell
Abstract
Background: Mortality from coronary heart disease in the United States has decreased substantially in recent decades. We conducted a study to determine how much of this decrease could be explained by the use of medical and surgical treatments as opposed to changes in cardiovascular risk factors.
Methods: We applied a previously validated statistical model, IMPACT, to data on the use and effectiveness of specific cardiac treatments and on changes in risk factors between 1980 and 2000 among U.S. adults 25 to 84 years old. The difference between the observed and expected number of deaths from coronary heart disease in 2000 was distributed among the treatments and risk factors included in the analyses.
Results: From 1980 through 2000, the age-adjusted death rate for coronary heart disease fell from 542.9 to 266.8 deaths per 100,000 population among men and from 263.3 to 134.4 deaths per 100,000 population among women, resulting in 341,745 fewer deaths from coronary heart disease in 2000. Approximately 47% of this decrease was attributed to treatments, including secondary preventive therapies after myocardial infarction or revascularization (11%), initial treatments for acute myocardial infarction or unstable angina (10%), treatments for heart failure (9%), revascularization for chronic angina (5%), and other therapies (12%). Approximately 44% was attributed to changes in risk factors, including reductions in total cholesterol (24%), systolic blood pressure (20%), smoking prevalence (12%), and physical inactivity (5%), although these reductions were partially offset by increases in the body-mass index and the prevalence of diabetes, which accounted for an increased number of deaths (8% and 10%, respectively).
Conclusions: Approximately half the decline in U.S. deaths from coronary heart disease from 1980 through 2000 may be attributable to reductions in major risk factors and approximately half to evidence-based medical therapies.
Copyright 2007 Massachusetts Medical Society.
Source: PubMed
Aankomende klinische onderzoeken
-
NCT07947342WervingLever neoplasmata | Hepatocellulair carcinoom
-
NCT07949019Nog niet aan het wervenGezondheidseducatie bij schoolkinderen
-
NCT07949890Nog niet aan het wervenNoodgeval operatie | Hypotension (MeSH: D007022)
-
NCT07948733WervingB-cel acute lymfoblastische leukemie (B-ALL) | B-cel non-Hodgkin lymfoom (NHL)
-
NCT07948720Nog niet aan het wervenFascia Iliaca-blok | Breuk dijbeen | DexMedetomidine analgesie
-
NCT07947524Nog niet aan het wervenAnesthesie | Preoperatieve zorg | Risicobeoordeling
-
NCT07949461Nog niet aan het wervenGezondheidsopleiding | Menstruele Gezondheid | Menstrual Poverty
-
NCT07949305Nog niet aan het wervenRacisme | Leeftijdsdiscriminatie | Seksisme | Gewicht vooroordeel | Ableism
-
NCT07948161Nog niet aan het wervenAutisme Spectrum Stoornis | Sensorische verwerkingsstoornis | Ouderschapsstress
-
NCT07947537Nog niet aan het wervenVoedsel-allergie | PDS (Prikkelbare Darm Syndroom) | IBD (Inflammatoire Darmziekte)
-
NCT07949292WervingDiabetes mellitus type 2
-
NCT07949357WervingOngerustheid | Bewuste sedatie | Ervaring van de patiënt